4/A//SEC Filing
Simpson Curran 4/A
Accession 0001562180-25-000360
CIK 0001590877other
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 5:19 PM ET
Size
6.2 KB
Accession
0001562180-25-000360
Insider Transaction Report
Form 4/AAmended
REGENXBIO Inc.RGNX
Simpson Curran
DirectorChief Executive Officer
Transactions
- Award
Stock Options (Right to buy)
2025-01-02+478,606→ 478,606 totalExercise: $7.86Exp: 2035-01-02→ Common Stock (478,606 underlying)
Footnotes (1)
- [F1]25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2026 while the optionee provides continuous service to the Issuer.
Documents
Issuer
REGENXBIO Inc.
CIK 0001590877
Entity typeother
Related Parties
1- filerCIK 0001346164
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 13, 7:00 PM ET
- Accepted
- Jan 14, 5:19 PM ET
- Size
- 6.2 KB